iShares U.S. Pharmaceuticals ETF (IHE)
NYSEARCA: IHE · Real-Time Price · USD
102.38
+0.39 (0.38%)
Jul 24, 2026, 4:00 PM EDT - Market closed
IHE Holdings Information
IHE is an equity ETF with a total of 60 individual holdings. The top holdings are Johnson & Johnson stock at 22.25%, Eli Lilly and Company at 21.36%, Bristol-Myers Squibb Company at 4.53%, Merck & Co. at 4.49%, and Viatris at 4.46%.
Total Holdings
60
Top 10 Percentage
75.56%
Asset Class
Equity
ETF Category
Health
Assets
1.47B
PE Ratio
23.36
Breakdown by Country
Top 25 Holdings
| No. | Symbol | Name | % Weight |
|---|---|---|---|
| 1 | JNJ | Johnson & Johnson | 22.25% |
| 2 | LLY | Eli Lilly and Company | 21.36% |
| 3 | BMY | Bristol-Myers Squibb Company | 4.53% |
| 4 | MRK | Merck & Co., Inc. | 4.49% |
| 5 | VTRS | Viatris Inc. | 4.46% |
| 6 | RPRX | Royalty Pharma plc | 4.43% |
| 7 | PFE | Pfizer Inc. | 4.00% |
| 8 | ZTS | Zoetis Inc. | 3.75% |
| 9 | JAZZ | Jazz Pharmaceuticals plc | 3.54% |
| 10 | ELAN | Elanco Animal Health Incorporated | 2.74% |
| 11 | AXSM | Axsome Therapeutics, Inc. | 2.31% |
| 12 | CORT | Corcept Therapeutics Incorporated | 2.05% |
| 13 | CRNX | Crinetics Pharmaceuticals, Inc. | 1.95% |
| 14 | LQDA | Liquidia Corporation | 1.39% |
| 15 | LGND | Ligand Pharmaceuticals Incorporated | 1.34% |
| 16 | DFTX | Definium Therapeutics, Inc. | 1.23% |
| 17 | INDV | Indivior Pharmaceuticals, Inc. | 1.09% |
| 18 | OGN | Organon & Co. | 0.79% |
| 19 | AMRX | Amneal Pharmaceuticals, Inc. | 0.69% |
| 20 | EWTX | Edgewise Therapeutics, Inc. | 0.66% |
| 21 | ELVN | Enliven Therapeutics, Inc. | 0.64% |
| 22 | SUPN | Supernus Pharmaceuticals, Inc. | 0.61% |
| 23 | ALMS | Alumis Inc. | 0.53% |
| 24 | NKTR | Nektar Therapeutics | 0.52% |
| 25 | MANE | Veradermics, Incorporated | 0.51% |
As of Jul 23, 2026